Professional Documents
Culture Documents
An IVR System
is NOT ONLY a
randomization system!
ClinPhoneivr applications
Site Management
Site activation
Site suspension
Payment to investigators
Track enrolment (country level/site level)
Control site activities through gatekeeper calls
Patient Management
ClinPhoneivr applications
Patient Direct
Diary cards
Psychiatric rating scales (HAM-D, HAM-A, Mental Health Screener,
the Leibowitz Social Anxiety Scale, Y-BOCS and WSAS)
Cognitive functions assessment (reaction, choice reaction, articulatory
working memory task, word recall and recognition)
Quality of Life questionnaires
Health Economics questionnaires
Reporting
Batch reports
Web reports
Data upload
IVR pre-screening
A patient contact method
Following direct advertising via radio, TV,
newspaper, magazines, flyers etc.
- USA: common practice
IVR pre-screening
A pre-qualification method
Diagnosis check
Psychiatric rating scales like the Mental Health
Screener to screen mood, anxiety, eating disorders
and other substance abuse, to identify potential
patients with evidence of depression)
Cognitive function assessments
Disease severity
Eligibility criteria
Demographics
Pre-Qualification
Referral
Via TV Advertising
Referral
From Site/community
Record Contact
Info
IVR HAM-D
Eligibility
Fax to closest
study centre
Call Centre
IVR call
Accelerated Recruitment in
Depression study
Centralised screening used in addition to study site activities
TOTAL # contacts
32,763
22,994
70%
# Pre-qualified
subjects
7,651
33%
#Pre-qualified
subjects to HAMD
5,755
75%
# Successful with
HAMD (>19)
3,774
66%
# passed on to sites
1,329
35%
Subjects randomised
677
51%(9%)
Accelerated Recruitment in
Depression study
Outcome:
394 and 283 subjects randomised on to the protocols
Protocol 1 fully enrolled in 12 weeks (saved 16 weeks)
Protocol 2 fully enrolled in 14 weeks (saved 7 weeks)
Study population
Major depressive disorder
N = 291
Assessments
Clinician rated HAM-D: weeks 0, 1, 2, 3, 4, 5, 6, 7, 8
IVR HAM-D recorded (from office): weeks 0, 1, 2, 3, 4, 5, 6, 7, 8
Clinician
60
40
30
20
20
0
10
20
30
40
Visit1HAMD17p
15
10
5
0
Visit 1
Qualification
10
20
40
25
IVR
30
40
10
20
30
40
40
30
30
20
20
20
30
40
10
0
Visit2HAMD17p
10
0
10
10
20
30
40
20
30
40
25
15
10
20
30
40
40
10
20
30
40
DeBrota et al.,
NCDEU, 1999
10 12
40
30
20
2
0
Visit9HAMD17p
10
0
30
Visit 3 HAMD17c
12
10
8
6
4
2
20
Visit 9 HAMD17p
40
10
Visit 3 HAMD17c
10
30
Visit 3 HAMD17p
20
20
40
30
20
Visit3HAMD17p
10
10
Visit 2 HAMD17c
10
15
10
5
0
Visit 2 HAMD17c
20
Visit 2 HAMD17p
Visit 9
Endpoint
Visit 1 HAMD17c
40
20
15
10
5
Visit 3
Randomisation
20
Visit 1 HAMD17c
Visit 2
Qualification
10
50
Visit 1 HAMD17p
10
20
30
Visit 9 HAMD17c
40
10
20
30
Visit 9 HAMD17c
40
IVR screening
A screening method
Eligibility criteria
Demographics
Additional diagnosis checks
Run-in treatment allocation
Asthma
Diabetes
Urinary incontinence
Gastro
Subjective symptoms
Quality of life
Questionnaire instruments
Generic instruments (eg SF-12, SF-36)
Disease-specific instruments
Data invented
Patient Adherence/Compliance
Case study:
Irritable bowel syndrome studies
Treatment period:
System availability:
Compliance:
Study 1:
Study 2:
Reference:
83%
81%
Patient Acceptability
How easy was it to use the IVR System? (n=449)
77
0
Very difficult
Neither easy
nor difficult
Easy
Difficult
15
Very Easy
100
90
80
70
60
% 50
40
30
20
10
0
Patient Acceptability
How easy was it to use the IVR system? (n = 874)
73
Very Easy
Easy
17
8
Difficult
Very Difficult
0
0
20
40
60
80
100
Measurements
Patients
Countries
Bronchitis
Symptom diary
800
N. America, S, America.
Pneumonia
Symptom diary
300
N. America, S, America.
800
1000
Far East
450
S. America
GERD
Symptom diary
700
Gastro paresis
Symptom diary
500
Depression
Cognitive function
800
USA
Depression
1400
USA
Depression
HAM-D
650
N. America
Depression
HAM-D
650
N. America
Pain
500
USA, UK
Migraine
Symptoms
300
N. America
Migraine
Symptoms
300
N. America
Migraine
Symptoms
470
Europe (9)